Oral steroid use in patients with the inflammatory diseases polymyalgia rheumatica and/or giant cell arteritis significantly increased the risk of infection, and the risk increased with higher doses
These recommendations were expected from Dr. Hoskins—what may be less obvious is his understanding of how major change is accomplished in Canadian health politics